Introduction
The Na/K pump (Na + , K + -ATPase, NKP) is a ubiquitous plasma membrane enzyme that catalyses the ATP-dependent transport of three Na + out of the cell and two K + into the cell, thereby generating a net outward pump current (I P ) in nearly all eukaryotic cells [1] . The functional NKP is composed of a catalytic α-subunit and a glycosylated β-subunit. Four α-subunit isoforms (α 1 -α 4 ) have been identified to date, and each has a unique tissue distribution and physiological role. The NKP α 1 -isoform acts as a "housekeeper" to maintain low intracellular Na + concentrations ( -exchanger and thus governs cardiomyocyte Ca 2+ levels and contractility [2, 3] . The NKP α-isoform-generated I P is based on different cardiac glycoside affinities of the isoforms: the NKP α 2 -isoform is cardiac glycoside-sensitive and generates the high-affinity pump current (I PH ), whereas the NKP α 1 -isoform is cardiac glycoside-resistant and generates the low affinity pump current (I PL ) [4, 5] . The I P is the sum of the I PL and I PH and is defined as the total NKP current. Furthermore, the I P is a significant component of the total net current during the plateau phase of the cardiac action potential [5] . Hence, the regulation of NKP function may directly affect the [Na + ] i and the duration of the plateau phase and thus myocardial functions, such as rhythm, conduction, and contraction force.
The NKP can be regulated by various factors, including adrenergic neurotransmitters. Several studies from Mathias's laboratory demonstrated that the adrenoreceptor can regulate the NKP. After a short-term (10 min) treatment of guinea pig myocytes, α-adrenoreceptor (α-AR) agonists increased the I PH without affecting the I PL , and β-adrenoreceptor (β-AR) agonists inhibited the I PL at low intracellular Ca 2+ concentrations ([Ca 2+ ] i ) but did not affect the I PH [5] [6] [7] [8] . However, although some evidence has indicated no effect [9, 10] or even inhibition during β-AR activation [5, 11, 12] , most results demonstrate α 1 -or α 2 -isoform stimulation after α-AR or β-AR activation [13] [14] [15] [16] [17] . These data are discrepant with the results from Mathias's laboratory, in which the short-term α-AR or β-AR agonist exposure had opposite effects on the I P by affecting specific NKP α-isoforms. Therefore, it is necessary to further confirm whether α-and β-AR activation has opposite and isoform-specific effects on the NKP in rat ventricular myocytes similar to guinea pig ventricular myocytes.
Many stressful conditions, including various cardiovascular diseases, such as chronic heart failure, myocardial ischaemia, myocardial hypertrophy, Takotsubo stress cardiomyopathy, and hypertension, induce a long-term elevation in circulating catecholamines, thereby altering NKP activity, which affects myocardial function. For example, diminished myocardial NKP activity and ouabain binding sites have been observed in patients and experimental animals with congestive heart failure [18] [19] [20] [21] , and cardiac ischaemia-induced α 1 -adrenergic activation decreases automaticity, resulting from α 1 -receptor-mediated stimulation of an outward current that is carried by the NKP, as well as a decrease in intracellular sodium levels [22] [23] [24] [25] . These data indicate that this alteration in NKP activity is caused, at least partially, by long-term heightened sympathetic nervous system activity. However, there are few reports regarding the regulatory effects of long-term adrenergic activation on the NKP. The present study sought to investigate the regulatory effect of long-term adrenergic activation on the NKP and the respective mechanisms of short-and long-term adrenergic regulation in isolated rat ventricular myocytes. -free Tyrode's solution containing the following (in mM): NaCl 140.0 (Sigma), KCl 5.4 (Sigma), MgCl 2 1.0 (Sigma), HEPES 10.0 (Merck, Germany), and D-glucose 10.0 (Sigma) that had been equilibrated with 100% O 2 (pH 7.4, adjusted with NaOH (Sigma)). This procedure was followed by 0.6% collagenase II perfusion (GIBCO, USA) in Ca
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-free Tyrode's solution for 15 min to digest the heart. Next, a piece of ventricle was cut out and teased into smaller pieces in Kraft-Brühe solution containing the following (in mM): KOH 80.0 (Sigma), KCl 40.0, KH 2 PO 4 25.0 (Sigma), MgSO 4 3.0 (Sigma), L-glutamic acid 50.0 (Alfa Asesar, Germany), taurine 20.0 (Sigma), HEPES 10.0, EGTA 1.0 (Sigma), and D-glucose 10.0 (pH 7.2, adjusted with KOH). All of the solutions were bubbled with 100% O 2 . The isolated cells were kept in Kraft-Brühe solution at room temperature for at least 1 h before the experiment. All of the experiments were performed within 36 h after ventricular myocyte isolation [26] .
Chemicals and treatments
All of the chemicals were purchased from Sigma. The α-AR was activated with noradrenaline after blocking the β-AR with propranolol. The β-AR was activated with isoprenaline, and prazosin was used to block the α 1 -AR. Stock solutions of 10 mM noradrenaline, 1 mM isoprenaline, 10 mM propranolol, 1 mM prazosin, 1 M strophanthidin, 50 mM dihydroouabain (DHO), 1 mM staurosporine, 10 mM H89, and 1 mM phalloidin were prepared with Milli-Q UF Plus water (Millipore) and stored at -20°C. The working concentrations were 1 μM isoprenaline, 10 μM noradrenaline, 10 μM propranolol, 1 μM prazosin, 1 μM staurosporine, 10 μM H89, and 1 μM phalloidin.
The cells were co-incubated with the α-AR agonist noradrenaline and propranolol or the β-AR agonist isoprenaline for 10 min (short-term) or 24 h (long-term) at room temperature. The other drugs were applied in the same manner as the noradrenaline and isoprenaline.
NKP current (IP) determination
We applied the whole-cell patch-clamp technique to examine the effects of α-AR and β-AR agonists on the I P in rat ventricular myocytes. α-AR activation was achieved by applying 10 μM noradrenaline in the presence of a β-AR blocker (10 μM propranolol), and β-AR activation was achieved by applying 1 μM isoprenaline. The I P generated by the NKP α 2 -and α 1 -isoforms were distinguished as the I PH and I PL , respectively, based on their affinities for cardiac glycosides; 5 μM DHO was used to detect the I PH , and 500 μM strophanthidin was used to detect the I PL in the presence of 5 μM DHO [7] . An Axopatch 700B amplifier (Axon Instruments, Inc.) was used to observe the cell membrane current. Patch pipette resistances were 2-4 MΩ before sealing. The pipette solutions contained the following (in mM): sodium aspartic acid 70.0 . For the external solutions, Ca 2+ was omitted, and Cd 2+ and Ba 2+ were added to suppress K + and Ca 2+ currents and Na + -Ca 2+ exchange. For the pipette solutions, K + was omitted, and ATP was added to suppress K + currents and activate the NKP in the forward mode. The cells were held at 0 mV after the formation of the whole-cell recording configuration. External solutions containing 5 μM DHO or 500 μM strophanthidin and 1 μM isoprenaline, 10 μM noradrenaline, 10 μM propranolol, 1 μM prazosin, or 1 μM phalloidin were perfused at 1.5-2 ml/min to observe changes in the I P . All of the patch-clamp data were recorded using the data acquisition program AxoScope 9.2 (Axon Instruments, Inc.) for subsequent analysis. The sampling rate was 200 ms/point, and the data were lowpass filtered at 2 kHz.
Immunoblots
Whole cell lysate preparation. The acutely isolated cells were first treated as described in the Chemicals and Treatments section and then lysed with ice-cold lysis buffer containing 50 mM Tris (pH 7.4), 150 mM NaCl, 5 mM EDTA, 0.5% Nonidet P-40 (NP-40), 0.5% Triton X-100, 0.1% SDS, 10% glycerol, and 10 µl/ml protease inhibitors. The cells were disrupted by sonication on ice using 4 × 2-s bursts. The supernatant (whole cell lysate) was collected by centrifugation at 120,000 × g for 30 min at 4°C, and the protein concentration was determined using the BCA Protein Assay Kit (Pierce). 
Cellular Physiology and Biochemistry
Plasma membrane protein preparation. After treating the cells with isoprenaline or noradrenaline (propranolol was co-incubated to block β-ARs) for 10 min, we used the Cell Surface Protein Isolation Kit (Thermo) to extract plasma membrane proteins according to the manufacturer's guidelines. This method involves four main steps: biotinylation, cell lysis, labelled protein isolation, and protein elution. Briefly, the cells were washed with pre-cooled phosphate-buffered saline (PBS, pH 7.2), which contained 100 mM sodium phosphate and 150 mM NaCl. The cells were then incubated with 1 mg/ml sulfo-NHS-SS biotin in PBS and gently agitated for 2 h at 4°C on a rocking platform. Unbound biotin was quenched with quenching solution containing 100 mM glycine for 15 min. The cells were washed with ice-cold PBS, lysed with lysis buffer, and disrupted by sonication on ice using five 1-s bursts. Cell suspensions were incubated for 30 min on ice, and the supernatants were collected by centrifugation. Protein concentrations of the supernatants were determined using the BCA Protein Assay Kit (Pierce). The supernatants were incubated overnight at 4°C with an equal amount of pre-washed immobilised streptavidin beads and centrifuged in micro-tubes for 2 min at top speed to collect the beads. The beads were washed four times with wash buffer, and SDS-PAGE sample buffer containing 50 mM DTT and bromophenol blue was added to the beads and incubated for 60 min at room temperature with end-over-end mixing on a rotator. The plasma membrane protein fractions were collected by centrifugation and analysed by western blot.
Endosome preparation. Early and late endosomes were fractionated on a flotation gradient according to the technique described by Gorvel et al. [27] . The cells in suspension (1.5 mg protein/ml) were incubated with AR agonists for 10 min. The incubation was terminated by transferring the samples to ice and adding cold homogenisation buffer containing 250 mM sucrose and 3 mM imidazole (pH 7.4). To minimise endosomal damage, the cells were gently homogenised, and the homogenate was subjected to a brief (5 min) centrifugation (4°C at 3,000 × g). The supernatant was collected and adjusted to 40.6% sucrose. The supernatant (1.5 ml) was then pipetted onto the bottom of a 5.0-ml centrifuge tube. Then, 1.5 ml of 16% sucrose, 1 ml of 10% sucrose, and 0.5 ml of homogenisation buffer were sequentially overlaid to form a density gradient. Density gradient centrifugation was performed at 110,000 × g for 60 min at 4°C in a Beckman ultracentrifuge. Early endosomes (EE) were collected at the 16%-10% sucrose interface, while late endosomes (LE) were collected at the homogenisation buffer-10% sucrose interface. The isolation of EE and LE was confirmed by immunoblotting with antibodies against rab5 and lamp1 proteins, markers for EE and LE, respectively.
Western blot analysis
Equal amounts of protein were separated by electrophoresis on 10% SDS-PAGE gels, transferred to polyvinylidene difluoride membranes (Immobilon-P, Millipore, Bedford, MA), and blocked for 1 h at 37°C in 5% non-fat dry milk in TBST. The following primary antibodies were used: NKP α 1 -isoform (Santa Cruz, 1:500), NKP α 2 -isoform (Upstate, 1:200), α 1 -AR (Abcam, 1:500), and β 1 -AR (Abcam, 1:500). Anti-mouse and anti-rabbit horseradish peroxidase-conjugated IgGs (KPL, 1:1000) were used as secondary antibodies. The blots were developed using the enhanced DAB chromogenic reagent kit. The signal intensity of each lane was quantified by densitometry; the drug-treated sample intensity was compared with the control sample intensity.
mRNA level determination
Total RNA was extracted from adult rat myocytes using the SV Total RNA Isolation System (Promega) according to the manufacturer's guidelines. RNA was eluted and immediately used as a template for cDNA synthesis. One microgram of total RNA was reverse transcribed using oligo (dT) primers with the Reverse Transcription System (Promega) according to the manufacturer's guidelines. The PCR primers were synthesised by Invitrogen. The specific primers are listed in Table 1 .
Reverse transcription polymerase chain reaction (RT-PCR)
The reverse transcription product (cDNA) was amplified using PCR with NKP α 1 -and α 2 -isoformspecific primers. Glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) was used as a housekeeping gene. The PCR reactions contained 2× GoTaq Green Master Mix, 10 μM forward primer, 10 μM reverse primer, 2 µl of template cDNA, and nuclease-free water in a final volume of 50 µl. The PCR protocol was as follows: denaturation (94°C for 5 min), denaturation, amplification, and extension for 30 cycles (94°C for 40 s, 45°C for 45 s, and 72°C for 45 s, respectively), followed by a final extension (72°C for 10 min). The PCR products were analysed by electrophoresis on 2% agarose gels followed by GoldView II nucleic acid staining.
Relative quantification of specific cDNAs by real-time PCR
To ensure reliability of our results, we chose two housekeeping genes (β-actin and GAPDH). These primers are listed in Table 1 . Real-time PCR was performed simultaneously for the NKP α 1 -and α 2 -isoforms, β-actin, and GAPDH in 48-well optical reaction plates in triplicate. Each reaction contained 1× SYBR Premix E x Taq (TaKaRa), 10 μM forward and reverse primers, and 2 µl of template cDNA in a final volume of 25 µl. The cycle conditions were as follows: denaturation (94°C for 5 min), denaturation, amplification, extension, and quantitation for 50 cycles (94°C for 40 s, 45°C for 45 s, and 72°C for 45 s, respectively, with a single fluorescence measurement), and a melt curve was performed at 60-95°C with a heating rate of 0.5°C/s and continuous fluorescence measurement. Cycle threshold (C t ) values were used to calculate the NKP α 1 -and α 2 -isoform mRNA expression relative to the housekeeping genes. All of the real-time PCR data were saved for subsequent analysis using the relative quantification method.
Statistical analysis
The data are expressed as the mean ± SE. The statistical discriminations were performed using Student's t-tests (paired and unpaired) or one-way ANOVA as appropriate, and P < 0.05 was considered to be significant.
Results
Short-term adrenergic activation regulates NKP activity in an isoform-specific manner
Rat ventricular myocytes express both the α 1 -and α 2 -NKP isoforms. As the affinity for cardiac glucoside is approximately 100-fold lower for the α 1 -than for the α 2 -isoform, the two α-isoforms can be assessed separately using different concentrations of cardiac glucoside; 5 μM DHO inhibits the α 2 -isoform only, and 500 μM strophanthidin (or 1 mM DHO) inhibits both α-isoforms. Thus, when the NKP-generated I P was assessed using the patch-clamp technique, the current that was sensitive to 5 μM DHO was identified as the α 2 -isoform-generated I PH , and the current that was sensitive to 500 μM strophanthidin in the presence of 5 μM DHO was identified as the α 1 -isoform-generated I PL . Figure 1A and 1B show the levels of I PL and I PH , respectively. The averages of the control I PL and I PH were 29.3 ± 8.1 pA (n = 7) and 12.2 ± 4.3 pA (n = 10), respectively. α-Adrenergic activation was achieved by applying 10 μM noradrenaline in the presence of a β-blocker (10 μM propranolol), and β-adrenergic activation was achieved by applying 1 μM isoprenaline. The I P value was normalised to the value obtained in the control condition. Our data demonstrated that shortterm β-adrenergic activation reduced the I PL but did not affect the I PH , whereas short-term α-adrenergic activation had no effect on the I PL but increased the I PH (Fig. 1) . These findings suggest that short-term α-and β-adrenergic activation have opposite effects on NKP activity [27] [28] [29] . Our results demonstrated that altered NKP activities are not associated with changes in α-isoform mRNA and protein expression levels following shortterm adrenergic activation. As the western blots were only able to quantify total wholecell NKP protein expression levels, it remained undetermined whether plasma membrane (active) NKP levels were affected. Therefore, we assessed NKP plasma membrane protein levels using protein biotinylation. After short-term α-or β-adrenergic activation, isolated myocytes were subjected to protein biotinylation to label surface NKP, and the amount of biotinylated NKP was estimated by western blot analysis. Our results demonstrated that short-term noradrenaline-mediated α-adrenergic activation increased α 2 -but not α 1 -isoform abundance on the plasma membrane, which was negated by incubation with prazosin, an α-AR antagonist (Fig. 3A) . This increase was accompanied by a corresponding decrease in α 2 -but not α 1 -isoform abundance in late endosomes but not in early endosomes (Fig. 3B) . These results suggest that short-term α-AR activation increases incorporation of the plasma membrane α 2 -isoform, which may result from α 2 -isoform recycling from late endosomes to the plasma membrane. Short-term isoprenaline-mediated β-adrenergic activation reduced The effects of short-term adrenergic activation on Na/K pump (NKP) protein and mRNA expression A) Western blot analysis of NKP α 1 -and α 2 -isoform protein levels in whole cells was performed using specific anti-α 1 and anti-α 2 antibodies. Equal protein amounts were loaded for each sample. The protein levels were normalised to Con, and the data are summarised in the histogram. Neither 1 μM ISO nor 10 μM NA (with 10 μM Pro) treatment affected NKP α 1 -and α 2 -isoform protein expression. B) Total RNA was amplified using NKP α 1 -and α 2 -isoform-specific primers. The products were subjected to electrophoresis on 2% agarose gels and visualised with GoldView. Amplification products at the predicted sizes (264 bp for the α 1 -isoform, 247 bp for the α 2 -isoform and 452 bp for GAPDH) were evident in RT-PCR reactions. The mean α 1 -and α 2 -isoform mRNA levels are demonstrated in the histogram. Neither ISO nor NA treatment affected NKP α 1 -and α 2 -isoform mRNA expression. C) For real-time PCR analysis, SYBR green, a non-specific fluorescent dye, was used to monitor gene amplification, and GAPDH and β-actin were used as two housekeeping genes to normalise α 1 -and α 2 -isoform mRNA expression levels. Neither ISO nor NA treatment affected NKP α 1 -and α 2 -isoform mRNA levels. Each column represents the mean value ± SE, and the number of myocytes studied is indicated within the column and comes from at least 3 different hearts.
α 1 -but not α 2 -isoform plasma membrane levels, which was reversed by incubation with the β-AR antagonist propranolol (Fig. 3A) . This reduction was accompanied by increased NKP α 1 -but not α 2 -isoform expression in early endosomes but not in late endosomes (Fig. 3B) . These results imply that short-term β-AR activation decreases plasma membrane incorporation of the α 1 -isoform, which may be a consequence of NKP α 1 -isoform translocation from the plasma membrane into early endosomes. Overall, these results suggest that short-term adrenergic activation alters the percentage of plasma membrane-localised NKP in cardiac myocytes by re-distributing the existing NKP from the plasma membrane and endosomal pools and does not affect NKP protein expression levels of either isoform in cardiomyocytes.
Phalloidin blocks actin-mediated NKP trafficking between the plasma membrane and the endosomes
Cells continuously internalise proteins from the plasma membrane to form early and late endosomes, which are then either recycled back to the membrane or transported to the lysosomes for degradation [30] . Actin polymerisation and depolymerisation provide a driving force for plasma membrane internalisation during endocytosis [31] as well as for endosomal The effects of short-term adrenergic activation on plasma membrane and endosomal NKP protein abundance After treatment with 1 μM ISO or 10 μM NA (with 10 μM Pro) for 10 min, plasma membrane proteins were extracted, and early and late endosomes (EE and LE, respectively) were fractionated by ultracentrifugation, with rab5 and lamp1 as markers for EE and LE, respectively. NKP α-isoform proteins in the plasma membrane and endosomes were analysed by western blot using specific anti-α 1 and anti-α 2 antibodies. Equal protein amounts were loaded for each sample. Protein levels were normalised to Con. A) NA treatment increased α 2 -but not α 1-isoform amounts on the plasma membrane, which was reversed by 1 μM prazosin (PZ) treatment, and ISO treatment decreased α 1 -but not the α 2-isoforms on the plasma membrane, which was reversed by treatment with 10 μM Pro. B) NA treatment decreased α 2 -but not α 1 -isoform levels in the LE but not the EE, and ISO treatment increased α 1 -but not the α 2 -isoform levels in the EE but not in the LE. Each column represents the mean value ± SE, and the number of myocytes studied is indicated within the column and comes from at least 3 different hearts. ★ P < 0.05, statistically significant relative to the Control.
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Long-term adrenergic activation affects NKP activity in an isoform-specific manner
To investigate the effects of long-term adrenergic activation on α 1 -and α 2 -NKP isoform activity, rat ventricular myocytes were isolated and incubated with isoprenaline or noradrenaline + propranolol at room temperature for 24 h, and NKP activity was assessed using the patch-clamp technique. The I P density was defined as the ratio of I P to capacitance. To assess the functional state of rat myocytes 24 h after isolation, their I P densities (pA/pF) were measured and compared with the measurements that were taken 1 h after isolation. The results demonstrated that the control I PL were 0.33 ± 0.04 and 0.35 ± 0.05 pA/pF, and the control I PH were 0.14 ± 0.03 and 0.15 ± 0.04 pA/pF, respectively, suggesting that myocyte NKP activity is not changed after 24 h in Kraft-Brühe solution at room temperature. However, after incubating 24 h with adrenergic agonists, β-adrenergic activation selectively increased the I PL but did not affect the I PH , and α-adrenergic activation reduced only the I PH and did not affect the I PL (Fig. 5A ). Our data demonstrate that long-term adrenergic NKP activity regulation is isoform-specific and that the effects of long-term α-and β-adrenergic activation are opposite of the short-term effects on NKP activity. These data suggest that long-term adrenergic NKP Fig 5. The effects of long-term adrenergic activation on I P , adrenoreceptor (AR) density, and NKP α-isoform expression After 1 μM ISO or 10 μM NA (with 10 μM Pro) treatment for 24 h, I P was assessed using the patchclamp technique. The I P density is defined as the ratio of I P to capacitance. Whole cell lysates were prepared, equal protein amounts were loaded for each sample, and western blot analysis was used to analyse AR and NKP α-isoform expression. AR density and α-isoform values were normalised to their corresponding Con. A) ISO treatment increased the low-affinity I P but had no effect on high-affinity I P , and NA treatment reduced the high-affinity I P but had no effect on the low-affinity I P . B) Western blot analysis using specific α 1 -AR and β 1 -AR antibodies; both ISO and NA treatment failed to alter α1-and β1-AR expression. C) Western blot analysis using specific anti-α 1 and anti-α 2 antibodies. ISO treatment up-regulated α 1 -isoform levels, which was reversed by 10 μM Pro treatment, but α 2 -isoform expression remained unaltered, whereas NA treatment down-regulated α 2 -but not α 1 -isoform levels, an effect that was reversed by 1 μM PZ treatment. Each column represents the mean value ± SE, and the number of myocytes studied is indicated within the columns and comes from at least 3 different hearts.
Yin et al.: Adrenergic Regulation of Cardiac NKP
Long-term adrenergic-mediated NKP regulation involves mRNA and protein expression level alterations
We next assessed α 1 -and α 2 -isoform mRNA and protein expression levels to explore the mechanism by which long-term adrenergic stimulation effects NKP activity. RT-PCR and quantitative real-time PCR were performed to examine NKP mRNA levels. The results (Fig. 6 ) demonstrated that following 24 h of β-adrenergic activation, α 1 -isoform mRNA levels were significantly up-regulated, while α 2 -isoform mRNA levels were unaltered. In contrast, α 2 -but not α 1 -isoform mRNA levels were significantly down-regulated after 24 h of α-adrenergic activation. Western blots (Fig. 5C ) from cardiac protein lysates further demonstrated that following 24 h of β-adrenergic activation, α 1 -isoform protein levels were significantly upregulated, while the α 2 -isoform protein levels were unaltered. Conversely, α 2 -but not α 1 -isoform protein levels were significantly down-regulated after 24 h of α-adrenergic activation. These data indicate that steady-state mRNA and protein levels were increased for the NKP α 1 -isoform and decreased for the α 2 -isoform, a result that corroborates those from the functional studies. Furthermore, NKP mRNA level alterations might result in subsequent NKP protein level changes, suggesting that NKP mRNA and protein level alterations could be the The roles of the PKA-and PKC-dependent pathways in the adrenergic NKP regulation Rat myocytes were treated with ISO, ISO + H89, ISO + staurosporine (Sta), NA, NA + H89 or NA + Sta for 10 min or 24 h; NA was co-incubated with Pro. The concentrations used were 1 μM ISO, 10 μM NA, 10 μM Pro, 10 μM H89, and 1 μM Sta. Plasma membrane protein and whole cell protein samples were prepared, and NKP α-isoform expression levels were determined by western blot using specific anti-α 1 and anti-α 2 antibodies. Equal protein amounts were loaded for each sample, and protein levels were normalised to Con. A) H89 treatment completely reversed the effect of ISO treatment on α 1 -isoform translocation, and Sta treatment blocked the effect of NA treatment on α 2 -isoform plasma membrane translocation following short-term adrenergic activation. B) Sta treatment reversed the reduction in the NA and H89 treatment-induced α 2 -isoform expression levels and abolished the increased ISO-induced α 1 -isoform expression levels in whole cells following long-term adrenergic activation. Each column represents the mean value ± SE, and the number of myocytes studied is indicated within the column and comes from at least 4 different hearts.
mechanism that underlies the isoform-specific regulation of NKP activity during long-term α-and β-adrenergic activation. The long-term β-adrenergic activation-mediated alterations in α 1 -isoform mRNA and protein levels were reversed by propranolol treatment, whereas the long-term α-adrenergic activation-mediated effects α 2 -isoform mRNA and protein levels were reversed by prazosin treatment, suggesting that the α 1 -and β 1 -ARs play a role in the events that decrease synthesis and/or increase degradation of the NKP α-isoforms.
PKA-and PKC-dependent pathways mediate the isoform-specific regulation of short-and long-term adrenergic NKP activation
Previously published studies from Mathias's laboratory demonstrated that short-term β-and α-adrenergic I P regulation is mediated by PKA and PKC, which are downstream β-and α-adrenergic activation signalling molecules, respectively, that play important roles in regulating α 1 -and α 2 -isoform activities in an isoform-specific manner [6] [7] [8] 11] . Here, we further assessed whether these downstream signalling pathways were also involved in the short-term adrenergic stimulation-mediated effects on the NKP α-isoform plasma membrane and endosomal localisation as well as the long-term adrenergic stimulation-mediated effects on the α-isoform in whole cells. We applied H89 and staurosporine to inhibit PKA and PKC, respectively. As demonstrated in Figure 7 , H89 but not staurosporine treatment completely reversed the short-term effects of isoprenaline treatment on the α 1 -isoform translocation, and staurosporine but not H89 treatment blocked the short-term effect of noradrenaline treatment on the α 2 -isoform translocation (Fig. 7A) . Furthermore, PKC but not PKA inhibition reversed the long-term α-adrenergic activation-induced reduction in α 2 -isoform expression, and PKA but not PKC inhibition abolished the long-term β-adrenergic activation-mediated increase in α 1 -isoform expression (Fig. 7B) . These results indicate that in rat ventricular myocytes, the effect of both short-and long-term β-AR activation on the α 1 -isoform involves the PKA-dependent pathway, and the effect of α-AR activation on the α 2 -isoform involves the PKC-dependent pathway. Although there are opposite consequences, the signalling pathways that are involved in the effects of long-term adrenergic activation on NKP α-isoform protein expression are the same compared with the short-term effects of adrenergic agonists on NKP α 1 -and α 2 -isoform translocation. These PKC-and PKA-dependent changes in mRNA and protein expression after adrenergic activation also provide further evidence supporting similar I P characteristics that were observed in guinea pig ventricular myocytes [6] [7] [8] 11] .
Discussion
The present study not only further confirmed that short-term α-AR and β-AR activation increased α 2 -isoform-generated I PH and decreased the α 1 -isoform-generated I PL, respectively, in rat myocytes similar to guinea pig ventricular myocytes [6] [7] [8] 11] but also demonstrated that long-term α-AR activation reduced α 2 -isoform-generated I PH and long-term β-AR activation increased the α 1 -isoform-generated I PL . These results suggest that either short-or long-term α-and β-AR activation mediate opposite effects on the I P in an α-isoform-specific manner, which may provide a balance between α-and β-AR activation on NKP function in cardiac myocytes [7] . Furthermore, the effect of either long-term α-or β-AR activation on the I P negatively feeds back on the short-term response, which may reduce arrhythmia risk in patients with cardiovascular diseases by limiting the elevated circulating catecholamineinduced [Na] i increase in stressful conditions.
In human hearts, all of the three α-isoforms are detected, and the estimated stoichiometric distribution is the α 1 -isoform being dominant (62%) over the α 2 -isoform (15%) and the α 3 -isoform (23%) [37] . Moreover, the inhibition of I P by DHO are also present in the cells, and the dissociation constants for inhibition by DHO are similar for the three α-isoforms [38] . The I P averaged from 12 atrial cells in the control were 0.29 ± 0.06 pA/pF [39] , which was similar to the I PH (0.33 ± 0.04 pA/pF) in this study and was significantly increased by α-but not β-adrenergic activation [39] . These results suggest that the I P in human atrial cells Figure 1C indicated a 26% increase of I PH by α-adrenergic activation, which is similar to the 24% increase in I PT observed in human atrial myocytes [39] ; therefore, the α 2 -isoform is responsible for approximately 100% of the I PT in human atrial myocytes, which is not consistent with this study in rat ventricular myocytes (29.5%) and the I PT in most reports (10-20%) [40, 41] . Moreover, β-adrenergic activation had no effect on the I PT in human atrium, which is also not consistent with the presence of the α 1 -isoform, unless α 1 -isoform regulation in human atrium differs from that in rat and guinea pig ventricle. Generally, the mechanism by which adrenergic activation regulates NKP is associated with a change in "working" NKP levels at the cell surface, which depends on the translocation and/or synthesis of α-isoform proteins. However, the present result indicates that long-but not short-term adrenergic activation altered whole cell α 1 -and α 2 -isoform protein or mRNA expression. It is possible that different α-isoform pools (plasma membrane and endosomal) are recruited for plasma membrane insertion or translocated to endosomes after plasma membrane invagination [28, 42] . Expectedly, short-term α-AR activation increased plasma membrane α 2 -isoform incorporation accompanied with a decrease of α 2 -isoform in late endosomes, and short-term β-AR activation decreased the content of plasma membrane α 1 -isoform accompanied with an increase of α 1 -isoform in early endosomes. These effects were prevented by stabilising the actin cytoskeleton with phalloidin, suggesting that shortterm adrenergic activation alters the percentage of plasma membrane-localised NKP in cardiomyocytes by re-distributing the existing NKP. These results indicate that the shortterm α-AR and β-AR activation-mediated increase in the I PH and reduction in the I PL cannot be attributed to α 2 -isoform synthesis or α 1 -isoform degradation in whole cells. Rather, this effect may be attributed to actin-mediated NKP protein trafficking between the plasma membrane and the endosomes to alter the number of functional plasma membrane-localised NKP without affecting total protein expression levels. Therefore, the short-term adrenergic activation-mediated NKP regulatory mechanism involves pre-existing NKP α-isoform translocation between the plasma membrane and the endosomes in an isoform-specific manner, which explains the isoform-specific regulation of the I P by short-term adrenergic activation.
Another important finding of the present study is that long-term adrenergic regulation of the I P and NKP α-isoform abundance by either α-or β-AR activation negatively feeds back on the short-term response. Considering that negative feedback is generally associated with altered effector density and that prolonged exposure to adrenergic agonists may upor down-regulate adrenoreceptor density [34, 43, 44] , we investigated whether long-term α-and β-adrenergic activation altered the respective receptor amounts. However, our data indicated that α-and β-adrenergic activation for 24 h failed to alter α 1 -and β 1 -AR expression levels, implying that the negative feedback on the I P by long-term α-and β-AR activation may be because of altered NKP α-isoform mRNA and protein expression levels but not myocardial α 1 -and β 1 -AR density. This result may also be because the 24 h incubation period was not long enough to initiate transcriptional and/or translational events because most adrenoreceptor down-regulation occurred after weeks or even months [34, 42, 45] . However, our data obtained from western blotting, RT-PCR, and real-time PCR analyses demonstrate that long-term α-AR activation decreased α 2 -isoform mRNA and protein levels and that longterm β-AR activation increased α 1 -isoform mRNA and protein levels in rat myocytes, further confirming that long-term adrenergic regulation involves protein synthesis or degradation. These results agree with the changes in the I P , suggesting that the reduced rat myocyte I PH may be associated with decreased α 2 -isoform mRNA and protein levels and that the increased I PL may be related to increased α 1 -isoform mRNA and protein expression levels.
Certain evidence has also indicated that increased NKP membrane expression via PKA or PKC-mediated phospholemman (PLM, FXYD1) phosphorylation [28, 42] may be involved in short-term adrenergic NKP regulation. PLM associates with NKP and mediates its adrenergic regulation in a tissue-specific manner [46] [47] [48] [49] [50] . PLM is the only FXYD protein family member that is present in cardiomyocytes, where it is a major substrate for PKA and , whereas PLM that has been phosphorylated by PKA or PKC relieves this inhibition and, thus, mediates PKA/PKC-dependent NKP stimulation during adrenergic activation [13, 16, 46, 50, 51] . Certain evidence indicated that β-AR-mediated PKA activation can target α 1 -and α 2 -isoformassociated PLM to increase the I P , whereas α-AR-mediated PKC activation can target α 2 -isoform-associated PLM to increase the I P [13, 41, 51] . Although this hypothesis is supported at least in part by the results from the present study, in the present study, β-AR activation targeted only the α 1 -isoform via the PKA-dependent pathway, and α-AR activation targeted only the α 2 -isoform via the PKC-dependent pathway. It is likely that PLM is required for the PKA-and PKC-mediated activity of the NKP, whereas the PLM phosphorylation state is regulated by the kinase activity of PKA and PKC and phosphatase activity of PP-1 and PP2-A. PKA and PKC phosphorylate PLM and, thus, stimulate NKP, whereas PP-1 and PP2-A remove phosphates from PLM and, thus, inhibit NKP [37] . Bibert et al. found that while PKA activation increases the apparent Na affinity of the α 1 -and α 2 -isoforms, PKC had no effect on the apparent Na affinity of either α 1 -or α 2 -isoform but increased the V max of the α 2 -isoform only [52] Furthermore, the activation of these pathways always had the opposite effects, suggesting that PLM phosphorylation is important, but is not the sole factor contributing to short-term adrenergic stimulation-mediated NKP regulation. Hence, NKP α-isoform translocation may be another short-term adrenergic regulatory mechanism, and the relationship of NKP α-isoform translocation and PLM phosphorylation during short-and long-term adrenergic activation deserves further investigation.
In summary, the results of the present study in rat cardiomyocytes demonstrate that NKP is regulated by adrenergic activation in an isoform-specific manner. The NKP α 2 -isoform is regulated by α-AR activation via a PKC-dependent pathway, and the α 1 -isoform is regulated by β-AR activation via a PKA-dependent pathway. The long-term adrenergic stimulationmediated NKP regulation negatively fed back on the short-term response. However, the NKP regulatory mechanism mainly involves the translocation of pre-existing NKP α-isoforms between the plasma membrane and the endosomes for short-term adrenergic activation, protein synthesis, and degradation for long-term adrenergic activation. These results suggest that the effect of changed NKP function (by long-term elevations in circulating catecholamine levels under stressful conditions of heart diseases) on heart function should be considered during cardiovascular disease treatment. However, considering the limitations of 24 h treatment with β-and α-adrenergic agonists as a model of chronic adrenergic stimulation, further in vivo studies are necessary to confirm the results of the present study and their functional significance. Yin 
